Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Ravdin

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|June 5, 2010
The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemopreventionPeter M Ravdin
Breast Disease|October 24, 2009
Hormone replacement therapy and the increase in the incidence of invasive lobular cancerPeter M Ravdin
Oncology (Williston Park, N.Y.)|December 22, 2004
Managing the risk of osteoporosis in women with a history of early breast cancerPeter M Ravdin
Lung Cancer (Amsterdam, Netherlands)|March 30, 2006
Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variablesPeter M Ravdin, Gregory Davis
Journal of the National Cancer Institute|July 27, 2007
Breast cancer trends: a marriage between clinical trial evidence and epidemiologyDonald A Berry, Peter M Ravdin
Journal of the National Comprehensive Cancer Network : JNCCN|September 23, 2009
Decision-making for patients with resectable breast cancer: individualized decisions for and by patients and their physiciansCharles L Loprinzi, Peter M Ravdin
Clinical Breast Cancer|October 28, 2004
A method for making estimates of the benefit of the late use of letrozole in patients completing 5 years of tamoxifenPeter M Ravdin, Gregory J Davis
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 3, 2015
Epidemiology of GIST in the Era of Histology Codes--LetterAlbert Lin, Ann W Hsing, Peter M Ravdin
Breast Cancer Research and Treatment|October 2, 2002
Choosing between endocrine therapy and chemotherapy--or is there a role for combination therapy?John F Forbes, William J Gradishar, Peter M Ravdin
Breast Cancer Research and Treatment|November 4, 2008
Sustained lower rates of breast cancer in the United StatesKathleen A Cronin, Peter M Ravdin, Brenda K Edwards
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cancer Prevention Research (Philadelphia, Pa.)|June 5, 2010
The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemopreventionPeter M Ravdin
Breast Disease|October 24, 2009
Hormone replacement therapy and the increase in the incidence of invasive lobular cancerPeter M Ravdin
Oncology (Williston Park, N.Y.)|December 22, 2004
Managing the risk of osteoporosis in women with a history of early breast cancerPeter M Ravdin
Lung Cancer (Amsterdam, Netherlands)|March 30, 2006
Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variablesPeter M Ravdin, Gregory Davis
Journal of the National Cancer Institute|July 27, 2007
Breast cancer trends: a marriage between clinical trial evidence and epidemiologyDonald A Berry, Peter M Ravdin
Journal of the National Comprehensive Cancer Network : JNCCN|September 23, 2009
Decision-making for patients with resectable breast cancer: individualized decisions for and by patients and their physiciansCharles L Loprinzi, Peter M Ravdin
Clinical Breast Cancer|October 28, 2004
A method for making estimates of the benefit of the late use of letrozole in patients completing 5 years of tamoxifenPeter M Ravdin, Gregory J Davis
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 3, 2015
Epidemiology of GIST in the Era of Histology Codes--LetterAlbert Lin, Ann W Hsing, Peter M Ravdin
Breast Cancer Research and Treatment|October 2, 2002
Choosing between endocrine therapy and chemotherapy--or is there a role for combination therapy?John F Forbes, William J Gradishar, Peter M Ravdin
Breast Cancer Research and Treatment|November 4, 2008
Sustained lower rates of breast cancer in the United StatesKathleen A Cronin, Peter M Ravdin, Brenda K Edwards
Pageof 4